Clene Statistics
Total Valuation
Clene has a market cap or net worth of $75.78 million. The enterprise value is $91.88 million.
| Market Cap | 75.78M |
| Enterprise Value | 91.88M |
Important Dates
The last earnings date was Thursday, May 14, 2026, before market open.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Clene has 12.78 million shares outstanding. The number of shares has increased by 39.83% in one year.
| Current Share Class | 12.78M |
| Shares Outstanding | 12.78M |
| Shares Change (YoY) | +39.83% |
| Shares Change (QoQ) | +7.95% |
| Owned by Insiders (%) | 8.72% |
| Owned by Institutions (%) | 26.53% |
| Float | 10.50M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 565.49 |
| Forward PS | 399.66 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 685.70 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.94
| Current Ratio | 1.94 |
| Quick Ratio | 1.40 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -7.35 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -56.06% |
| Return on Invested Capital (ROIC) | -137.09% |
| Return on Capital Employed (ROCE) | -141.06% |
| Weighted Average Cost of Capital (WACC) | 9.52% |
| Revenue Per Employee | $1,696 |
| Profits Per Employee | -$424,215 |
| Employee Count | 79 |
| Asset Turnover | 0.01 |
| Inventory Turnover | 0.50 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +34.16% in the last 52 weeks. The beta is 0.92, so Clene's price volatility has been similar to the market average.
| Beta (5Y) | 0.92 |
| 52-Week Price Change | +34.16% |
| 50-Day Moving Average | 6.34 |
| 200-Day Moving Average | 6.56 |
| Relative Strength Index (RSI) | 47.72 |
| Average Volume (20 Days) | 108,544 |
Short Selling Information
The latest short interest is 1.13 million, so 8.81% of the outstanding shares have been sold short.
| Short Interest | 1.13M |
| Short Previous Month | 1.32M |
| Short % of Shares Out | 8.81% |
| Short % of Float | 10.72% |
| Short Ratio (days to cover) | 0.90 |
Income Statement
In the last 12 months, Clene had revenue of $134,000 and -$33.51 million in losses. Loss per share was -$3.17.
| Revenue | 134,000 |
| Gross Profit | 111,000 |
| Operating Income | -21.07M |
| Pretax Income | -33.51M |
| Net Income | -33.51M |
| EBITDA | -19.62M |
| EBIT | -21.07M |
| Loss Per Share | -$3.17 |
Balance Sheet
The company has $5.94 million in cash and $22.05 million in debt, with a net cash position of -$16.11 million or -$1.26 per share.
| Cash & Cash Equivalents | 5.94M |
| Total Debt | 22.05M |
| Net Cash | -16.11M |
| Net Cash Per Share | -$1.26 |
| Equity (Book Value) | -18.81M |
| Book Value Per Share | -1.60 |
| Working Capital | 6.29M |
Cash Flow
In the last 12 months, operating cash flow was -$18.06 million and capital expenditures -$39,000, giving a free cash flow of -$18.10 million.
| Operating Cash Flow | -18.06M |
| Capital Expenditures | -39,000 |
| Depreciation & Amortization | 1.45M |
| Net Borrowing | 1.03M |
| Free Cash Flow | -18.10M |
| FCF Per Share | -$1.42 |
Margins
| Gross Margin | 82.84% |
| Operating Margin | -15,722.39% |
| Pretax Margin | -25,009.70% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Clene does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -39.83% |
| Shareholder Yield | -39.83% |
| Earnings Yield | -44.23% |
| FCF Yield | -23.89% |
Analyst Forecast
The average price target for Clene is $32.20, which is 443.00% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $32.20 |
| Price Target Difference | 443.00% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 839.34% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 11, 2024. It was a reverse split with a ratio of 1:20.
| Last Split Date | Jul 11, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
Clene has an Altman Z-Score of -22.49 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -22.49 |
| Piotroski F-Score | 3 |